ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2026
Limited pelvic radiotherapy in post-operative uterine carcinoma.
Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adjuvant external beam radiotherapy (EBRT) is a standard of care for all patients with intermediate and high-risk uterine carcinomas. In EBRT, target volume includes tumour bed along with pelvic lymph nodes. However, benefit of nodal irradiation in patients with negative nodes after an adequate pelvic lymph node dissection is unclear. This retrospective study aims to analyse outcome of limited pelvic radiotherapy (LPRT) in postoperative carcinoma of cervix and endometrium. Materials and methods: All postoperative carcinoma of cervix and endometrium cases treated with adjuvant LPRT from January 2013 to December 2023 were included in the analysis. Patients were treated to a dose of 5040 cGy using 3-dimensional conformal radiotherapy. In patients with cervical stroma involvement, along with an EBRT dose of 4500 cGy, high dose rate (HDR) brachytherapy was also delivered. We plan analysed patterns of failure, overall survival (OS), recurrence-free survival (RFS), and treatment-associated toxicities. Results: Out of 391 screened postoperative carcinoma cervix and endometrium patients, 37 received LPRT. With a median follow-up of 51.1 months, 2 patients were lost to follow-up. The 5-year RFS and OS were 75.5% and 73.2%, respectively. Among 4 patients who developed recurrence during the 5-year analysis period, all had distant recurrences. Grade ≥ 2 gastrointestinal and genitourinary toxicities were observed in 29.7% of patients in acute phase and 2.7% as late effects. Lymphedema occurred in 8.1%, with no Grade 4 or 5 toxicities reported. Conclusions: LPRT without lymph node irradiation results in good local control in the selected group of post operative uterine carcinomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.